Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Blood-based biomarkers of Alzheimer s disease: challenging but feasible Thambisetty M; Lovestone SBiomark Med 2010[Feb]; 4 (1): 65-79Blood-based biomarkers present a considerable challenge: technically, as blood is a complex tissue and conceptually, as blood lacks direct contact with brain. Nonetheless, increasing evidence suggests that there is a blood protein signature, and possibly a transcript signature, that might act to increase confidence in diagnosis, be used to predict progression in either disease or prodromal states, and that may also be used to monitor disease progression. Evidence for this optimism comes partly from candidate protein studies, including those suggesting that amyloid-beta measures might have value in prediction and those studies of inflammatory markers that consistently show change in Alzheimer's disease, and partly from true proteomics studies that are beginning to identify markers in blood that replicate across studies and populations.|Alzheimer Disease/*blood/diagnosis/genetics[MESH]|Amyloid beta-Peptides/blood[MESH]|Apolipoproteins E/genetics[MESH]|Biomarkers/*blood[MESH]|C-Reactive Protein/metabolism[MESH]|Genetic Markers[MESH]|Homocysteine/blood[MESH]|Humans[MESH]|Longitudinal Studies[MESH]|Proteomics[MESH]|RNA/blood/genetics[MESH] |